"Glioblastoma therapy" trang 1 - tải miễn phí từ tailieunhanh
Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: Efects on cell death, self-renewal, and invasion

Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: Efects on cell death, self-renewal, and invasion
23    1    1
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma

VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma
7    40    1
Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6- methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma

Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6- methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma
12    58    1
Multiple formin proteins participate in glioblastoma migration

Multiple formin proteins participate in glioblastoma migration
11    82    1
Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: A retrospective study

Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: A retrospective study
8    89    0
Complete clinical regression of a BRAF V600Emutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

Complete clinical regression of a BRAF V600Emutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
5    54    1
Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: An observational study of a cohort of consecutive non-selected patients from a single institution

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: An observational study of a cohort of consecutive non-selected patients from a single institution
11    41    1
Use of Bevacizumab in recurrent glioblastoma: A scoping review and evidence map

Use of Bevacizumab in recurrent glioblastoma: A scoping review and evidence map
23    8    1
Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma
7    48    1
Study protocol for a multicenter randomised controlled trial on the (cost)effectiveness of biopsy combined with same-session MRguided LITT versus biopsy alone in patients with primary irresectable glioblastoma (EMITT trial)

Study protocol for a multicenter randomised controlled trial on the (cost)effectiveness of biopsy combined with same-session MRguided LITT versus biopsy alone in patients with primary irresectable glioblastoma (EMITT trial)
8    1    1
Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma

Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma
11    6    1
GENE THERAPY DEVELOPMENTS AND FUTURE PERSPECTIVES

GENE THERAPY DEVELOPMENTS AND FUTURE PERSPECTIVES
366    67    0
Secondary glioblastoma after treatment of intracranial germinoma - would radiationonly therapy still be safe? Case report

Secondary glioblastoma after treatment of intracranial germinoma - would radiationonly therapy still be safe? Case report
4    40    1
Crosslink between Temozolomide and PDL1 immune-checkpoint inhibition in glioblastoma multiforme

Crosslink between Temozolomide and PDL1 immune-checkpoint inhibition in glioblastoma multiforme
7    94    1
WORK AMONG THE ELDERLY

WORK AMONG THE ELDERLY

189    87    0
Breast Cancer: Early Detection

Breast Cancer: Early Detection

1    86    0
PLASTIC WASTE IN THE ENVIRONMENT

PLASTIC WASTE IN THE ENVIRONMENT

171    98    0
From Hospitals to Healthcare Coalitions: Transforming Health Preparedness and Response in Our Communities

From Hospitals to Healthcare Coalitions: Transforming Health Preparedness and Response in Our Communities

150    90    0
AIR POLLUTION-RELATED BURDEN OF ILLNESS IN TORONTO: 2004 UPDATE

AIR POLLUTION-RELATED BURDEN OF ILLNESS IN TORONTO: 2004 UPDATE
38    54    0
iSeries e-business Handbook - A Technology and Product Reference

iSeries e-business Handbook - A Technology and Product Reference
346    66    0